Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis

NCT07650942 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: Hemay005 tablet
DRUG: Placebo
DRUG: Hemay005 tablet
DRUG: Placebo

Sponsor

Ganzhou Hemay Pharmaceutical Co., Ltd